nifedipine has been researched along with Sclerosis, Systemic in 60 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 7.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| "The case is reported of successful conception and pregnancy in a woman with systemic sclerosis while receiving continuous treatment with nifedipine 30 mg/day, after a previously poor obstetric record and involuntary secondary infertility." | 7.68 | Successful pregnancy in a woman with systemic sclerosis while taking nifedipine. ( Kirby, JD; Wilson, AG, 1990) |
| "A 64-year-old woman with systemic sclerosis and pulmonary hypertension underwent Swan-Ganz catheterization to test her response to the calcium channel blocker nifedipine." | 7.67 | Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis. ( Fudman, EJ; Kelling, DG, 1985) |
| " During 12 weeks of prednisone treatment in a dosage of 40 mg daily, her condition markedly deteriorated clinically and hemodynamically as manifested by pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR), cardiac output (CO), mixed venous O2 saturation, and systemic vascular resistance (SVR)." | 5.28 | Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome. ( Dresner-Feigin, R; Galun, E; Glikson, M; Pollack, A; Rubinow, A, 1990) |
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 3.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| "The case is reported of successful conception and pregnancy in a woman with systemic sclerosis while receiving continuous treatment with nifedipine 30 mg/day, after a previously poor obstetric record and involuntary secondary infertility." | 3.68 | Successful pregnancy in a woman with systemic sclerosis while taking nifedipine. ( Kirby, JD; Wilson, AG, 1990) |
| "A 64-year-old woman with systemic sclerosis and pulmonary hypertension underwent Swan-Ganz catheterization to test her response to the calcium channel blocker nifedipine." | 3.67 | Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis. ( Fudman, EJ; Kelling, DG, 1985) |
| "The study cohort included patients with systemic sclerosis (SSc; n = 20), primary Raynaud's phenomenon (n = 15) or 'autoimmune Raynaud's' (n = 5)." | 2.69 | Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. ( Black, CM; Bruckdorfer, KR; Bunce, TD; Denton, CP; Dorado, MB; Howell, K; Roberts, Z; Wilson, H, 1999) |
| "Iloprost was administered intravenously (2 ng/kg/min for a period of 8 h)." | 2.68 | Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis. ( Bazzi, S; Berruti, V; Castagnone, D; Mascagni, B; Quarto di Palo, F; Rivolta, R; Scorza, R, 1997) |
| "Twenty patients with systemic sclerosis, Raynaud's phenomenon (19 of 20 patients), and clinically normal cardiac function underwent right heart catheterization." | 2.67 | Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. ( Kyriakidis, CA; Kyriakidis, MK; Mavrikakis, ME; Psarros, TK; Sfikakis, PP; Toutouzas, PK; Vergos, CG; Vyssoulis, GP, 1991) |
| "Patients with systemic sclerosis reacted as well as patients with primary Raynaud's phenomenon." | 2.66 | Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects. ( Thien, T; van 't Laar, A; Wollersheim, H, 1987) |
| "Cardiac tamponade is uncommon in both SSc as well as hypothyroidism, unlike in our patient who was found to have both of these disorders." | 1.39 | Recurrent cardiac tamponade in a young woman. ( Itolikar, M; Itolikar, SM; Phatak, S; Salagre, S, 2013) |
| "Nifedipine is a Ca(++)-channel antagonist that has been used for a long time in Raynaud's phenomenon treatment." | 1.34 | Nifedipine effect on red cell rheological properties in patients with systemic scleroderma. ( Bertoluzzo, SM; Contesti, JF; Leroux, MB; Parente, FM; Spengler, MI; Svetaz, MJ, 2007) |
| "Nifedipine treatment considerably decreased O2*- production by PMA-stimulated monocytes." | 1.33 | Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis. ( Allanore, Y; Borderie, D; Ekindjian, OG; Kahan, A; Lemaréchal, H; Périanin, A, 2005) |
| "Nifedipine treatment led to a significant increase in the MRI perfusion index (mean (SD) 0." | 1.33 | Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. ( Allanore, Y; Duboc, D; Kahan, A; Legmann, P; Meune, C; Pascal, O; Vignaux, O; Weber, S, 2005) |
| "Nifedipine treatment led to a significant decrease in concentrations of sVCAM-1, carbonyl residues, and AOPP but did not affect concentrations of VEGF and sVEGFR-1." | 1.32 | Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1. ( Allanore, Y; Borderie, D; Ekindjian, OG; Kahan, A; Lemaréchal, H, 2004) |
| "Treatment with nifedipine did not significantly change any of the pulmonary function values, except for the carbon monoxide diffusing capacity (DLCO)." | 1.28 | Diffusing capacity of the lung and nifedipine in systemic sclerosis. ( Georgiakodis, F; Kyriakidis, M; Papazoglou, S; Sfikakis, P; Sfikakis, PP; Toutouzas, P; Vergos, C, 1990) |
| " During 12 weeks of prednisone treatment in a dosage of 40 mg daily, her condition markedly deteriorated clinically and hemodynamically as manifested by pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR), cardiac output (CO), mixed venous O2 saturation, and systemic vascular resistance (SVR)." | 1.28 | Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome. ( Dresner-Feigin, R; Galun, E; Glikson, M; Pollack, A; Rubinow, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (51.67) | 18.7374 |
| 1990's | 18 (30.00) | 18.2507 |
| 2000's | 7 (11.67) | 29.6817 |
| 2010's | 2 (3.33) | 24.3611 |
| 2020's | 2 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Varghese, B | 1 |
| Chew, E | 1 |
| Konig, MF | 1 |
| Abignano, G | 1 |
| Mennillo, GA | 1 |
| Lettieri, G | 1 |
| Itolikar, SM | 1 |
| Salagre, S | 1 |
| Phatak, S | 1 |
| Itolikar, M | 1 |
| Calderaro, DC | 1 |
| de Carvalho, MA | 1 |
| Moretzsohn, LD | 1 |
| Benomar, S | 1 |
| Boutayeb, S | 1 |
| Benzekri, L | 1 |
| Senouci, K | 1 |
| Errihani, H | 1 |
| Hassam, B | 1 |
| Wahezi, DM | 1 |
| Ilowite, NT | 1 |
| Kenney-Riley, KM | 1 |
| Belamarich, PF | 1 |
| Allanore, Y | 3 |
| Borderie, D | 2 |
| Lemaréchal, H | 2 |
| Ekindjian, OG | 2 |
| Kahan, A | 7 |
| Périanin, A | 1 |
| Vignaux, O | 1 |
| Meune, C | 1 |
| Pascal, O | 1 |
| Duboc, D | 2 |
| Weber, S | 3 |
| Legmann, P | 1 |
| Spengler, MI | 1 |
| Leroux, MB | 1 |
| Svetaz, MJ | 1 |
| Contesti, JF | 1 |
| Parente, FM | 1 |
| Bertoluzzo, SM | 1 |
| Fontenelle, SM | 1 |
| Kayser, C | 1 |
| Pucinelli, ML | 1 |
| Andrade, LE | 1 |
| Connolly, SM | 1 |
| Woo, TY | 1 |
| Wong, RC | 1 |
| Campbell, JP | 1 |
| Goldfarb, MT | 1 |
| Voorhees, JJ | 1 |
| Callen, JP | 1 |
| Winston, EL | 1 |
| Pariser, KM | 1 |
| Miller, KB | 1 |
| Salem, DN | 1 |
| Creager, MA | 1 |
| Gouet, D | 1 |
| Rouffineau, J | 1 |
| Marechaud, R | 1 |
| Thomas, P | 1 |
| Pourrat, O | 1 |
| Alcalay, M | 1 |
| Bontoux, D | 1 |
| Ocken, S | 1 |
| Reinitz, E | 1 |
| Strom, J | 1 |
| Amor, B | 4 |
| Menkes, CJ | 4 |
| Jaffe, IA | 1 |
| Morgan, EB | 1 |
| Grassi, W | 1 |
| Core, P | 1 |
| Carlino, G | 1 |
| Cervini, C | 1 |
| Ward, WA | 1 |
| Van Moore, A | 1 |
| Aikimbaev, KS | 1 |
| Oğuz, M | 1 |
| Ozbek, S | 1 |
| Demirtaş, M | 1 |
| Birand, A | 1 |
| Batyraliev, T | 1 |
| Bergemann, A | 1 |
| Tikly, M | 1 |
| Scorza, R | 1 |
| Rivolta, R | 1 |
| Mascagni, B | 1 |
| Berruti, V | 1 |
| Bazzi, S | 1 |
| Castagnone, D | 1 |
| Quarto di Palo, F | 1 |
| Denton, CP | 2 |
| Bunce, TD | 1 |
| Dorado, MB | 1 |
| Roberts, Z | 1 |
| Wilson, H | 1 |
| Howell, K | 2 |
| Bruckdorfer, KR | 1 |
| Black, CM | 2 |
| Dziadzio, M | 1 |
| Smith, R | 1 |
| Blann, A | 1 |
| Bowers, E | 1 |
| Haustein, UF | 1 |
| Dawnay, A | 1 |
| Wilson, AG | 2 |
| Lamb, E | 1 |
| Kirby, JD | 4 |
| Cattell, WR | 1 |
| Alpert, MA | 2 |
| Pressly, TA | 2 |
| Mukerji, V | 2 |
| Lambert, CR | 1 |
| Mukerji, B | 1 |
| Panayiotou, H | 1 |
| Sharp, GC | 2 |
| Barr, WG | 1 |
| Maziere, B | 1 |
| Loc'h, C | 1 |
| Crouzel, C | 1 |
| Strauch, G | 1 |
| Guérin, F | 2 |
| Syrota, A | 1 |
| Sfikakis, PP | 3 |
| Kyriakidis, MK | 1 |
| Vergos, CG | 1 |
| Vyssoulis, GP | 1 |
| Psarros, TK | 1 |
| Kyriakidis, CA | 1 |
| Mavrikakis, ME | 1 |
| Toutouzas, PK | 1 |
| Langevitz, P | 1 |
| Buskila, D | 1 |
| Lee, P | 1 |
| Hercz, G | 1 |
| Kyriakidis, M | 1 |
| Vergos, C | 1 |
| Papazoglou, S | 1 |
| Georgiakodis, F | 1 |
| Toutouzas, P | 1 |
| Sfikakis, P | 1 |
| Belch, JJ | 2 |
| Glikson, M | 1 |
| Pollack, A | 1 |
| Dresner-Feigin, R | 1 |
| Galun, E | 1 |
| Rubinow, A | 1 |
| O'Dowd, A | 1 |
| Forbes, CD | 1 |
| Sturrock, RD | 1 |
| Guseva, NG | 2 |
| Poltyrev, AS | 1 |
| Alekseev, VI | 1 |
| Anikina, NV | 1 |
| Shcherbakov, AB | 2 |
| Rademaker, M | 2 |
| Cooke, ED | 1 |
| Almond, NE | 1 |
| Beacham, JA | 1 |
| Smith, RE | 1 |
| Mant, TG | 1 |
| Orvoen-Frija, E | 1 |
| Dore, MF | 1 |
| Fiessinger, JN | 2 |
| Rochemaure, J | 1 |
| Riccio, A | 2 |
| Pennarola, R | 1 |
| Farinaro, C | 2 |
| Scherillo, G | 1 |
| Infranzi, E | 1 |
| Del Puente, A | 2 |
| Oriente, P | 2 |
| Grossman, JA | 1 |
| Barrall, DT | 1 |
| Dennison, A | 1 |
| Lally, EV | 1 |
| Cases, A | 1 |
| Bosch, X | 1 |
| Campistol, JM | 1 |
| Botey, A | 1 |
| Revert, L | 1 |
| Meyrick Thomas, RH | 1 |
| Grimes, SM | 1 |
| MacKay, A | 1 |
| Kovacs, IB | 1 |
| Cook, ED | 1 |
| Bowcock, SM | 1 |
| Winkler, A | 1 |
| Jackson, RW | 1 |
| Benge, JM | 1 |
| Wollersheim, H | 1 |
| Thien, T | 1 |
| van 't Laar, A | 1 |
| Devaux, JY | 1 |
| Nitenberg, A | 1 |
| Venot, A | 1 |
| Degeorges, M | 1 |
| Roucayrol, JC | 1 |
| Jean, F | 1 |
| Aubert, A | 1 |
| Bloch, F | 1 |
| Petite, JP | 1 |
| Priollet, P | 1 |
| Husson, JM | 1 |
| Billaud, E | 1 |
| Scarpa, R | 1 |
| Rocco, P | 1 |
| Gioia, M | 1 |
| Grisanti, M | 1 |
| Vicencio, M | 1 |
| Wigley, FM | 1 |
| Malamet, R | 1 |
| Wise, RA | 1 |
| Czirják, L | 1 |
| Szegedi, G | 1 |
| Thakur, SK | 1 |
| Gopinathan, VP | 1 |
| Jagdish, TK | 1 |
| Bhalla, IP | 1 |
| Shetty, KJ | 1 |
| Finch, MB | 1 |
| Dawson, J | 1 |
| Johnston, GD | 1 |
| Bour, B | 1 |
| Couturier, D | 1 |
| Ellis, WW | 1 |
| Baer, AN | 1 |
| Robertson, RM | 1 |
| Pincus, T | 1 |
| Kronenberg, MW | 1 |
| Mach, ES | 1 |
| Ohar, J | 1 |
| Polatty, C | 1 |
| Robichaud, A | 1 |
| Fowler, A | 1 |
| Vetrovec, G | 1 |
| Glauser, F | 1 |
| Fudman, EJ | 1 |
| Kelling, DG | 1 |
3 reviews available for nifedipine and Sclerosis, Systemic
| Article | Year |
|---|---|
Scleroderma: therapeutic options.
Topics: Alprostadil; Captopril; Colchicine; Griseofulvin; Humans; Immunosuppressive Agents; Nifedipine; Peni | 1984 |
[Current status and trends in treatment of scleroderma].
Topics: Captopril; Combined Modality Therapy; Dextrans; Epoprostenol; Humans; Immunosuppressive Agents; Nife | 1992 |
Current topics in the diagnosis and treatment of scleroderma.
Topics: Adult; Female; Humans; Nifedipine; Penicillamine; Scleroderma, Systemic | 1991 |
15 trials available for nifedipine and Sclerosis, Systemic
| Article | Year |
|---|---|
Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
Topics: Administration, Sublingual; Adult; Cold Temperature; Cross-Over Studies; Double-Blind Method; Drug M | 2008 |
Acute effects of single dose nifedipine on cold-induced changes of microvascular dynamics in systemic sclerosis.
Topics: Administration, Oral; Adult; Aged; Capillaries; Capillary Permeability; Cold Temperature; Dose-Respo | 1994 |
Management of finger ulcers in scleroderma.
Topics: Adult; Algorithms; Anti-Infective Agents, Local; Chronic Disease; Combined Modality Therapy; Fingers | 1995 |
Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis.
Topics: Brachial Artery; Female; Humans; Iloprost; Kidney Cortex; Middle Aged; Nifedipine; Prospective Studi | 1997 |
Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
Topics: Anticholesteremic Agents; Antioxidants; Ascorbic Acid; Cohort Studies; Humans; Lipoproteins; Lipopro | 1999 |
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.
Topics: Adult; Aged; Female; Humans; Losartan; Male; Middle Aged; Nifedipine; Pilot Projects; Raynaud Diseas | 1999 |
Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril.
Topics: Administration, Oral; Adult; Captopril; Cardiac Catheterization; Cardiovascular Diseases; Exercise T | 1991 |
[Correction of microcirculatory disorders in rheumatic diseases].
Topics: Administration, Oral; Clinical Trials as Topic; Dextrans; Dipyridamole; Disseminated Intravascular C | 1985 |
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Topics: Administration, Oral; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Metho | 1989 |
Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
Topics: Blood Flow Velocity; Clinical Trials as Topic; Double-Blind Method; Humans; Nifedipine; Raynaud Dise | 1987 |
Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Flow Velocity; Female; Hemodynamics; Humans; Ma | 1987 |
Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis.
Topics: Adult; Aged; Benzazepines; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Esophageal Dise | 1986 |
Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Topics: Adult; Cold Temperature; Double-Blind Method; Female; Fingers; Humans; Imidazoles; Lupus Erythematos | 1987 |
The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
Topics: Adolescent; Adult; Aged; Female; Fingers; Humans; Male; Middle Aged; Nifedipine; Raynaud Disease; Re | 1986 |
Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric study.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Gastroesophageal Reflux; Humans; Male; Ma | 1985 |
42 other studies available for nifedipine and Sclerosis, Systemic
| Article | Year |
|---|---|
Digit Ulcerations in a Young Woman.
Topics: Female; Fingers; Humans; Ischemia; Nifedipine; Photography; Raynaud Disease; Scleroderma, Systemic; | 2020 |
Foot ulcers in systemic sclerosis escape surgical amputation.
Topics: Aged; Analgesics, Opioid; Anti-Bacterial Agents; Drug Therapy, Combination; Factor Xa Inhibitors; Fe | 2020 |
Recurrent cardiac tamponade in a young woman.
Topics: Adult; Cardiac Tamponade; Cardiomegaly; Cyclophosphamide; Female; Humans; Hypothyroidism; Nifedipine | 2013 |
Esophageal manometry in 28 systemic sclerosis Brazilian patients: findings and correlations.
Topics: Adult; Antibodies, Antinuclear; Autoantigens; Brazil; Calcium Channel Blockers; DNA Topoisomerases, | 2009 |
[Limited 5-fluorouracil-induced systemic scleroderma].
Topics: Adult; Antimetabolites, Antineoplastic; Calcium Channel Blockers; Colectomy; Colonic Neoplasms; Fema | 2009 |
Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood.
Topics: Adolescent; Bosentan; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Leg Ulcer; Nifedip | 2011 |
Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.
Topics: Biomarkers; Blood Proteins; Female; Hospitalization; Humans; Male; Middle Aged; Neovascularization, | 2004 |
Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.
Topics: Aged; Antioxidants; Calcium Channel Blockers; Cells, Cultured; Drug Evaluation; Female; Humans; Male | 2005 |
Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis.
Topics: Adult; Aged; Coronary Circulation; Echocardiography, Doppler; Female; Humans; Image Processing, Comp | 2005 |
Nifedipine effect on red cell rheological properties in patients with systemic scleroderma.
Topics: Adult; Blood Viscosity; Calcium Channel Blockers; Erythrocyte Deformability; Female; Hemorheology; H | 2007 |
Nifedipine in scleroderma ulcerations.
Topics: Aged; Female; Humans; Leg Ulcer; Nifedipine; Scleroderma, Systemic; Time Factors | 1984 |
Nifedipine as a therapeutic modality for Raynaud's phenomenon.
Topics: Adult; Blood Pressure; Creatinine; Double-Blind Method; Female; Fingers; Humans; Male; Middle Aged; | 1983 |
[Arterial hypertension with secondary hyperaldosteronism, reversible by nifedipine, in systemic scleroderma].
Topics: Aged; Female; Humans; Hyperaldosteronism; Hypertension; Nifedipine; Scleroderma, Systemic | 1983 |
Nifedipine treatment for pulmonary hypertension in a patient with systemic sclerosis.
Topics: Cardiac Catheterization; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Pyridines; | 1983 |
Nifedipine in digital ulceration in scleroderma.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nifedipine; Pyridines; Scleroderma, Systemic; Skin U | 1983 |
Nifedipine in digital ulceration in scleroderma.
Topics: Adult; Female; Humans; Nifedipine; Pyridines; Raynaud Disease; Scleroderma, Systemic; Skin Ulcer | 1982 |
Nifedipine treatment for scleroderma.
Topics: Female; Humans; Middle Aged; Nifedipine; Pyridines; Scleroderma, Systemic | 1982 |
Comparative assessment of the effects of vasodilators on peripheral vascular reactivity in patients with systemic scleroderma and Raynaud's phenomenon: color Doppler flow imaging study.
Topics: Adult; Captopril; Cold Temperature; Female; Fingers; Humans; Male; Nifedipine; Nitroglycerin; Pulsat | 1996 |
Cystic lung disease in systemic sclerosis: a case report with high resolution computed tomography findings.
Topics: Adult; Antirheumatic Agents; Cysts; Female; Humans; Lung Diseases; Nifedipine; Penicillamine; Pulmon | 1996 |
Microalbuminuria in systemic sclerosis.
Topics: Adult; Aged; Albuminuria; Creatinine; Female; Humans; Male; Middle Aged; Nifedipine; Prospective Stu | 1992 |
Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
Topics: Adult; Blood Pressure; Calcinosis; Cardiac Catheterization; Cardiac Output; Dyspnea; Esophageal Moti | 1991 |
The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study.
Topics: Animals; Coronary Circulation; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; | 1991 |
Scleroderma hypertensive renal crisis and the changing pattern of mortality in systemic sclerosis (scleroderma)
Topics: Adult; Captopril; Female; Humans; Hydralazine; Hypertension, Renal; Kidney; Male; Middle Aged; Minox | 1991 |
Diffusing capacity of the lung and nifedipine in systemic sclerosis.
Topics: Adult; Carbon Monoxide; Drug Administration Schedule; Female; Hemodynamics; Humans; Lung Diseases; M | 1990 |
Successful pregnancy in a woman with systemic sclerosis while taking nifedipine.
Topics: Adult; Female; Foot Diseases; Humans; Infant, Newborn; Infertility, Female; Male; Nifedipine; Pregna | 1990 |
The phenomenon, syndrome and disease of Maurice Raynaud.
Topics: Antibodies, Antinuclear; Autoantibodies; Blood Circulation; Blood Vessels; Humans; Microcirculation; | 1990 |
Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome.
Topics: Adult; Drug Therapy, Combination; Esophageal Motility Disorders; Hemodynamics; Humans; Hypertension, | 1990 |
Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.
Topics: Adult; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Iloprost; Middle Aged; | 1985 |
[Effect of a single dose of nifedipine on the CO transfer capacity in patients with scleroderma].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nifedipine; Pulmonary Diffusing Capacity; Scleroderm | 1989 |
[Capillaroscopic evaluation of the effects of nifedipine in patients with Raynaud's phenomenon].
Topics: Adult; Aged; Capillaries; Female; Hand; Humans; Male; Microscopy; Middle Aged; Nifedipine; Raynaud D | 1988 |
Successful combined medical and surgical treatment of a lower extremity sclerodermal ulcer.
Topics: Aged; Aspirin; Combined Modality Therapy; Debridement; Dipyridamole; Etidronic Acid; Female; Humans; | 1988 |
Captopril vs. nifedipine.
Topics: Acute Kidney Injury; Captopril; Female; Humans; Middle Aged; Nifedipine; Scleroderma, Systemic | 1987 |
Value and limitations of calcium channel blockade in the treatment of pulmonary hypertension associated with CREST--case reports.
Topics: Adult; Calcinosis; Diltiazem; Esophageal Diseases; Female; Humans; Hypertension, Pulmonary; Male; Mi | 1988 |
Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis.
Topics: Adult; Aged; Cardiac Catheterization; Cardiomyopathies; Coronary Circulation; Female; Humans; Male; | 1986 |
Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
Topics: Adult; Aged; Body Temperature; Female; Humans; Male; Middle Aged; Nifedipine; Raynaud Disease; Scler | 1987 |
[Pulmonary involvement in progressive systemic sclerosis].
Topics: Humans; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Penicillamine; Pulmonary Fibrosis; Scler | 1986 |
Nifedipine treatment for progressive systemic sclerosis.
Topics: Humans; Nifedipine; Scleroderma, Systemic | 1986 |
Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
Topics: Adult; Female; Humans; Nifedipine; Raynaud Disease; Scleroderma, Systemic | 1986 |
Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis.
Topics: Adult; Cold Temperature; Female; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Hypothermia | 1986 |
[Corinfar in the treatment of Raynaud's syndrome in systemic scleroderma (preliminary results)].
Topics: Adult; Female; Fingers; Humans; Male; Middle Aged; Nifedipine; Raynaud Disease; Regional Blood Flow; | 1985 |
The role of vasodilators in patients with progressive systemic sclerosis. Interstitial lung disease and pulmonary hypertension.
Topics: Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Pulmonary Fibrosis; Sarcoid | 1985 |
Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
Topics: Female; Hemodynamics; Humans; Hypertension, Pulmonary; Middle Aged; Nifedipine; Scleroderma, Systemi | 1985 |